{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:27:36Z","timestamp":1740108456444,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00296-020-04588-3","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T12:03:54Z","timestamp":1588075434000},"page":"1143-1149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Tocilizumab treatment in Felty\u2019s syndrome"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0314-2090","authenticated-orcid":false,"given":"Rongda","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4338-6233","authenticated-orcid":false,"given":"Qi","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0347-811X","authenticated-orcid":false,"given":"Pan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9355-1500","authenticated-orcid":false,"given":"Shufen","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4431-1535","authenticated-orcid":false,"given":"Qiuju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5831-5334","authenticated-orcid":false,"given":"Xiaoxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0567-4955","authenticated-orcid":false,"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2525-6099","authenticated-orcid":false,"given":"Li","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"issue":"5","key":"4588_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.berh.2004.05.002","volume":"18","author":"GP Balint","year":"2004","unstructured":"Balint GP, Balint PV (2004) Felty\u2019s syndrome. Best Pract Res Clin Rheumatol 18(5):631\u2013645. https:\/\/doi.org\/10.1016\/j.berh.2004.05.002","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"4588_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00296-007-0366-x","volume":"28","author":"S Ish-Hurwitz","year":"2007","unstructured":"Ish-Hurwitz S, Dovrish Z, Edelstein E, Bernheim J, Bernheim J, Hadari R, Amital H (2007) Diffuse disseminated candidiasis in a patient with Felty\u2019s syndrome: a case report. Rheumatol Int 28(1):65\u201368. https:\/\/doi.org\/10.1007\/s00296-007-0366-x","journal-title":"Rheumatol Int"},{"key":"4588_CR3","volume-title":"Felty syndrome. Stat Pearls [Internet]","author":"R Patel","year":"2020","unstructured":"Patel R, Akhondi H (2020) Felty syndrome. Stat Pearls [Internet]. Stat Pearls Publishing, Treasure Island"},{"issue":"8","key":"4588_CR4","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/rheumatology\/37.8.908","volume":"37","author":"S Wassenberg","year":"1998","unstructured":"Wassenberg S, Herborn G, Rau R (1998) Methotrexate treatment in Felty\u2019s syndrome. Br J Rheumatol 37(8):908\u2013911. https:\/\/doi.org\/10.1093\/rheumatology\/37.8.908","journal-title":"Br J Rheumatol"},{"issue":"3","key":"4588_CR5","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3892\/ol.2013.1779","volume":"7","author":"RZ Xiao","year":"2014","unstructured":"Xiao RZ, Xiong MJ, Long ZJ, Fan RF, Lin DJ (2014) Diagnosis of Felty\u2019s syndrome, distinguished from hematological neoplasm: a case report. Oncol Lett 7(3):713\u2013716. https:\/\/doi.org\/10.3892\/ol.2013.1779","journal-title":"Oncol Lett"},{"issue":"7","key":"4588_CR6","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.3324\/haematol.11819","volume":"92","author":"M Mah\u00e9vas","year":"2007","unstructured":"Mah\u00e9vas M, Audia S, De Lastours V, Michel M, Bonotte B, Godeau B (2007) Neutropenia in Felty\u2019s syndrome successfully treated with hydroxychloroquine. Haematologica 92(7):e78\u2013e79. https:\/\/doi.org\/10.3324\/haematol.11819","journal-title":"Haematologica"},{"issue":"4","key":"4588_CR7","first-page":"868","volume":"28","author":"F Talip","year":"2001","unstructured":"Talip F, Walker N, Khan W, Zimmermann B (2001) Treatment of Felty\u2019s syndrome with leflunomide. J Rheumatol 28(4):868\u2013870","journal-title":"J Rheumatol"},{"issue":"3","key":"4588_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.5152\/eurjrheumatol.2014.026","volume":"1","author":"A Yaz\u0131c\u0131","year":"2014","unstructured":"Yaz\u0131c\u0131 A, U\u00e7ar A, Mehtap \u00d6, G\u00f6n\u00fcll\u00fc E\u00d6, Tamer A (2014) Presentation of three cases followed up with a diagnosis of Felty syndrome. Eur J Rheumatol 1(3):120\u2013122. https:\/\/doi.org\/10.5152\/eurjrheumatol.2014.026","journal-title":"Eur J Rheumatol"},{"issue":"2","key":"4588_CR9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/ard.2004.025643","volume":"64","author":"C Sordet","year":"2005","unstructured":"Sordet C, Gottenberg JE, Hellmich B, Kieffer P, Mariette X, Sibilia J (2005) Lack of efficacy of rituximab in Felty\u2019s syndrome. Ann Rheum Dis 64(2):332\u2013333. https:\/\/doi.org\/10.1136\/ard.2004.025643","journal-title":"Ann Rheum Dis"},{"key":"4588_CR10","doi-asserted-by":"publisher","first-page":"312","DOI":"10.2174\/1874312901206010312","volume":"6","author":"L Heylen","year":"2012","unstructured":"Heylen L, Dierickx D, Vandenberghe P, Westhovens R (2012) Targeted therapy with rituximab in Felty\u2019s syndrome: a case report. Open Rheumatol J 6:312\u2013314. https:\/\/doi.org\/10.2174\/1874312901206010312","journal-title":"Open Rheumatol J"},{"issue":"5","key":"4588_CR11","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.semarthrit.2011.08.008","volume":"41","author":"J Narv\u00e1ez","year":"2012","unstructured":"Narv\u00e1ez J, Domingo-Domenech E, G\u00f3mez-Vaquero C, L\u00f3pez-Vives L, Estrada P, Aparicio M, Mart\u00edn-Esteve I, Nolla JM (2012) Biological agents in the management of Felty\u2019s syndrome: a systematic review. Semin Arthritis Rheum 41(5):658\u2013668. https:\/\/doi.org\/10.1016\/j.semarthrit.2011.08.008","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"4588_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00393-014-1380-5","volume":"73","author":"H Becker","year":"2014","unstructured":"Becker H, Appel H, Fassbinder T (2014) Rituximab for treatment of Felty\u2019s syndrome. Z Rheumatol 73(5):465\u2013468. https:\/\/doi.org\/10.1007\/s00393-014-1380-5","journal-title":"Z Rheumatol"},{"issue":"6","key":"4588_CR13","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jbspin.2012.01.013","volume":"79","author":"AL Tomi","year":"2012","unstructured":"Tomi AL, Liot\u00e9 F, Ea HK (2012) One case of Felty\u2019s syndrome efficiently treated with rituximab. Jt Bone Spine 79(6):624\u2013625. https:\/\/doi.org\/10.1016\/j.jbspin.2012.01.013","journal-title":"Jt Bone Spine"},{"issue":"4","key":"4588_CR14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1080\/03009742.2017.1334816","volume":"47","author":"CR Wang","year":"2018","unstructured":"Wang CR, Chiu YC, Chen YC (2018) Successful treatment of refractory neutropenia in Felty\u2019s syndrome with rituximab. Scand J Rheumatol 47(4):340\u2013341. https:\/\/doi.org\/10.1080\/03009742.2017.1334816","journal-title":"Scand J Rheumatol"},{"issue":"Suppl 2","key":"4588_CR15","doi-asserted-by":"publisher","first-page":"ii35","DOI":"10.1136\/annrheumdis-2013-consensusapp","volume":"72","author":"DE Furst","year":"2013","unstructured":"Furst DE, Fleischman R, Kalden J, Kavanaugh A, Sieper J, Mease P, Smolen J, Breedveld F (2013) Documentation of off-label use of biologics in rheumatoid arthritis. Ann Rheum Dis 72(Suppl 2):ii35\u2013ii51. https:\/\/doi.org\/10.1136\/annrheumdis-2013-consensusapp","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"4588_CR16","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1182\/blood.V74.8.2769.2769","volume":"74","author":"BP Hazenberg","year":"1989","unstructured":"Hazenberg BP, Van Leeuwen MA, Van Rijswijk MH, Stern AC, Vellenga E (1989) Correction of granulocytopenia in Felty\u2019s syndrome by granulocyte-macrophage colony-stimulating factor. Simultaneous induction of interleukin-6 release and flare-up of the arthritis. Blood 74(8):2769\u20132770","journal-title":"Blood"},{"issue":"3","key":"4588_CR17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/s0268-960x(96)90024-7","volume":"10","author":"EJ Rashba","year":"1996","unstructured":"Rashba EJ, Rowe JM, Packman CH (1996) Treatment of the neutropenia of Felty syndrome. Blood Rev 10(3):177\u2013184. https:\/\/doi.org\/10.1016\/s0268-960x(96)90024-7","journal-title":"Blood Rev"},{"issue":"1","key":"4588_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2174\/1573397115666190506152729","volume":"16","author":"MA Aghdashi","year":"2019","unstructured":"Aghdashi MA, Khadir M, Dinparasti-Saleh R (2019) Antinuclear antibodies and lupus-like manifestations in rheumatoid arthritis and ankylosing spondylitis patients at 4 months\u2019 follow-up after treatment with infliximab and etanercept. Curr Rheumatol Rev 16(1):61\u201366. https:\/\/doi.org\/10.2174\/1573397115666190506152729","journal-title":"Curr Rheumatol Rev"},{"issue":"7","key":"4588_CR19","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1136\/ard.2004.032110","volume":"64","author":"A Ghavami","year":"2005","unstructured":"Ghavami A, Genevay S, Fulpius T, Gabay C (2005) Etanercept in treatment of Felty\u2019s syndrome. Ann Rheum Dis 64(7):1090\u20131091. https:\/\/doi.org\/10.1136\/ard.2004.032110","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"4588_CR20","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1080\/21645515.2017.131690","volume":"13","author":"M Sheppard","year":"2017","unstructured":"Sheppard M, Laskou F, Stapleton PP, Hadavi S, Dasgupta B (2017) Tocilizumab (Altera). Hum Vaccin Immunother 13(9):1972\u20131988. https:\/\/doi.org\/10.1080\/21645515.2017.131690","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"4588_CR21","doi-asserted-by":"publisher","first-page":"e0123392","DOI":"10.1371\/journal.pone.0123392","volume":"10","author":"J Narv\u00e1ez","year":"2015","unstructured":"Narv\u00e1ez J, D\u00edaz-Torn\u00e9 C, Magallares B, Hern\u00e1ndez MV, Reina D, Corominas H, Sanmart\u00ed R, de la Serna AR, Llobet JM, Nolla JM (2015) Comparative effectiveness of tocilizumab with either methotrexate or leflunomide in the treatment of rheumatoid arthritis. PLoS ONE 10(4):e0123392. https:\/\/doi.org\/10.1371\/journal.pone.0123392","journal-title":"PLoS ONE"},{"issue":"4","key":"4588_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jbspin.2015.01.005","volume":"82","author":"E Lazaro","year":"2015","unstructured":"Lazaro E, Morel J (2015) Management of neutropenia in patients with rheumatoid arthritis. Jt Bone Spine 82(4):235\u2013239. https:\/\/doi.org\/10.1016\/j.jbspin.2015.01.005","journal-title":"Jt Bone Spine"},{"issue":"3","key":"4588_CR23","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jbspin.2014.12.001","volume":"82","author":"F Verhoeven","year":"2015","unstructured":"Verhoeven F, Guillot X, Prati C, Wendling D (2015) Treatment of pseudo Felty\u2019s syndrome: is there a place for rituximab? Jt Bone Spine 82(3):196\u2013199. https:\/\/doi.org\/10.1016\/j.jbspin.2014.12.001","journal-title":"Jt Bone Spine"},{"issue":"1\u20132","key":"4588_CR24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12026-014-8590-4","volume":"61","author":"O Shovman","year":"2015","unstructured":"Shovman O, Shoenfeld Y, Langevitz P (2015) Tocilizumab-induced neutropenia in rheumatoid arthritis patients with previous history of neutropenia: case series and review of literature. Immunol Res 61(1\u20132):164\u2013168. https:\/\/doi.org\/10.1007\/s12026-014-8590-4","journal-title":"Immunol Res"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04588-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04588-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04588-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:41:04Z","timestamp":1659112864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-020-04588-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["4588"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04588-3","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"type":"print","value":"0172-8172"},{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2020,4,28]]},"assertion":[{"value":"12 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. All authors fulfilled the ICMJE authorship criteria.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the individual participant included in the study. Informed consent was obtained from this patient for publication of this case report and any accompanying images. A copy of this consent is available to the editors of the journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}